Ratio 125%: reformulate [RSABE / ABEL]

posted by Ohlbe – France, 2012-05-09 18:40 (5146 d 05:16 ago) – Posting: # 8547
Views: 10,006

Dear drsinghs,

❝ Ok if my study is for EMA and observed ratio for AUCt is 125% with 90% CI 110 lower and 140 upper, Can I expect 90% CI to be within 80.00-125.00% in replicate design study.


If your observed T/R ratio is 125 %, your chances to get a 90 % CI within 80.00 - 125.00 % in the next study, even with a replicate design, are close to nil.

Regards
Ohlbe

Regards
Ohlbe

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,570 registered users;
249 visitors (0 registered, 249 guests [including 157 identified bots]).
Forum time: 23:57 CEST (Europe/Vienna)

There are no dangerous thoughts;
thinking itself is dangerous.    Hannah Arendt

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5